Stacy S Shord
11PUBLICATIONS
96CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Dosages for First-in-Human Trials.Hao Zhu, Alex N Phipps, Ying Yuan
|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Early-Phase Trials Using Innovative Trial Designs and Biomarkers.Olanrewaju O Okusanya, Gabriela I Patilea-Vrana, Anthony Sireci
|Oct 02, 2025
FDA-AACR Strategies for Optimizing Dosages for Oncology Drug Products: Selecting Optimized Dosages for Registrational Trials.Stacy S Shord, Cong Chen, Jin Y Jin
|Aug 27, 2025
FDA Approval Summary: Datopotamab Deruxtecan-dlnk for Treatment of Patients with Unresectable or Metastatic, HR-Positive, HER2-Negative Breast Cancer.Melanie Royce, Mirat Shah, Lijun Zhang
|Jun 05, 2025
Using Quantitative Approaches to Optimize Dosages for New Combinations and Subsequent Indications for Oncology Drugs.Wei Gao, Jiang Liu, Cynthia J Musante
|May 06, 2025
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better.Kristin M Wessel, Nicole Drezner, Stacy S Shord
Pageof 2
Frequent Collaborators
3 joint publications
Martha Donoghue
3 joint publications
Patricia M LoRusso
3 joint publications
Mirat Shah
3 joint publications
Claudia P Miller
3 joint publications
Brad A Davidson
3 joint publications
Nicole Drezner
3 joint publications
Richard Pazdur
3 joint publications
Jiang Liu
2 joint publications
Marc R Theoret
2 joint publications
Diana Bradford
